bluuebunny/crossref_metadata_2025 huggingface dataset:
Figure S1 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
Authors: Ji Jennifer X. , Cochrane Dawn R. , Tessier-Cloutier Basile , Chen Shary Yutin , Ho Germain , Pathak Khyatiben V. , Alcazar Isabel N. , Farnell David , Leung Samuel , Cheng Angela , Chow Christine , Colborne Shane , Negri Gian Luca , Kommoss Friedrich , Karnezis Anthony , Morin Gregg B. , McAlpine Jessica N. , Gilks C. Blake , Weissman Bernard E. , Trent Jeffrey M. , Hoang Lynn , Pirrotte Patrick , Wang Yemin , Huntsman David G.
Published: April 2023

ASS1 immunohistochemistry in 15 cases of SCCOHT. Different areas (small cell, large cell, rhabdoid) are represented for some cases. Representative cores for each area for each case are shown. Final histoscore for each case is the highest score among all areas.
Supplementary Data from Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Authors: Luke Jason J. , Onderdonk Benjamin E. , Bhave Sandeep R. , Karrison Theodore , Lemons Jeffrey M. , Chang Paul , Zha Yuanyuan , Carll Tim , Krausz Thomas , Huang Lei , Martinez Carlos , Janisch Linda A. , Hseu Robyn D. , Moroney John W. , Patel Jyoti D. , Khodarev Nikolai N. , Salama Joseph K. , Ott Patrick A. , Fleming Gini F. , Gajewski Thomas F. , Weichselbaum Ralph R. , Pitroda Sean P. , Chmura Steven J.
Published: April 2023

Supplemental Methods, Figures, and Tables
Supplementary Table S1 from Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators
Authors: Huh Jung Wook , Tanksley Jarred , Chino Junzo , Willett Christopher G. , Dewhirst Mark W.
Published: April 2023

Summary of Patient Related Factors Associated with Pelvic Radiation Disease
Supplementary Data 7 from Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma
Authors: Bachet Jean-Baptiste , Blons Hélène , Hammel Pascal , Hariry Iman El , Portales Fabienne , Mineur Laurent , Metges Jean-Philippe , Mulot Claire , Bourreau Camille , Cain Jason , Cros Jérôme , Laurent-Puig Pierre
Published: April 2023

Interaction between the presence of ctDNA at baseline and eryaspase efficacy on PFS and OS
Supplementary Data 4 from Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma
Authors: Bachet Jean-Baptiste , Blons Hélène , Hammel Pascal , Hariry Iman El , Portales Fabienne , Mineur Laurent , Metges Jean-Philippe , Mulot Claire , Bourreau Camille , Cain Jason , Cros Jérôme , Laurent-Puig Pierre
Published: April 2023

Multivariate analysis of prognostic factors at baseline
Supplementary Table S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Authors: Fraunhoffer Nicolas A. , Abuelafia Analía Meilerman , Bigonnet Martin , Gayet Odile , Roques Julie , Telle Emmanuel , Santofimia-Castaño Patricia , Borrello María Teresa , Chuluyan Eduardo , Dusetti Nelson , Iovanna Juan
Published: April 2023

Supplementary Table S1
Supplementary Figure S1 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Authors: Fraunhoffer Nicolas A. , Abuelafia Analía Meilerman , Bigonnet Martin , Gayet Odile , Roques Julie , Telle Emmanuel , Santofimia-Castaño Patricia , Borrello María Teresa , Chuluyan Eduardo , Dusetti Nelson , Iovanna Juan
Published: April 2023

Supplementary Figure S1
Table S5 from TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Authors: Rosen Ezra Y. , Goldman Debra A. , Hechtman Jaclyn F. , Benayed Ryma , Schram Alison M. , Cocco Emiliano , Shifman Sophie , Gong Yixiao , Kundra Ritika , Solomon James P. , Bardelli Alberto , Scaltriti Maurizio , Drilon Alexander , Iasonos Alexia , Taylor Barry S. , Hyman David M.
Published: April 2023

Supplemental Table 5. Recurrence-Free, Progression-Free, and Overall Survival Estimates.
Figure S5 from TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Authors: Rosen Ezra Y. , Goldman Debra A. , Hechtman Jaclyn F. , Benayed Ryma , Schram Alison M. , Cocco Emiliano , Shifman Sophie , Gong Yixiao , Kundra Ritika , Solomon James P. , Bardelli Alberto , Scaltriti Maurizio , Drilon Alexander , Iasonos Alexia , Taylor Barry S. , Hyman David M.
Published: April 2023

Supplemental Figure 5. Timeline for Patients with Emergent or Lost TRK Fusions.
Supplementary Table S1: Properties of Antibody Isotypes from Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
Authors: Aggen David H. , Drake Charles G. , Rini Brian I.
Published: April 2023

Immunoglobulin Isotypes and Relative Biologic Properties
Figure S4 from TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations
Authors: Rosen Ezra Y. , Goldman Debra A. , Hechtman Jaclyn F. , Benayed Ryma , Schram Alison M. , Cocco Emiliano , Shifman Sophie , Gong Yixiao , Kundra Ritika , Solomon James P. , Bardelli Alberto , Scaltriti Maurizio , Drilon Alexander , Iasonos Alexia , Taylor Barry S. , Hyman David M.
Published: April 2023

Supplemental Figure 4. Pathologic and preclinical characterization of melanoma with concurrent GON4L-NTRK1 and NRAS Q61R mutations.
Table S3 from Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non–Small Cell Lung Cancer
Authors: Cooper Alissa J. , Kobayashi Yoshihisa , Kim Dewey , Clifford Sarah E. , Kravets Sasha , Dahlberg Suzanne E. , Chambers Emily S. , Li Jiaqi , Rangachari Deepa , Nguyen Tom , Costa Daniel B. , Rabin Michael S. , Wagle Nikhil , Sholl Lynette M. , Jänne Pasi A , Oxnard Geoffrey R.
Published: April 2023

Post-baseline toxicity incidence.
Supplementary Fig. S6 from Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression
Authors: Tanimoto Azusa , Matsumoto Shingo , Takeuchi Shinji , Arai Sachiko , Fukuda Koji , Nishiyama Akihiro , Yoh Kiyotaka , Ikeda Takaya , Furuya Naoki , Nishino Kazumi , Ohe Yuichiro , Goto Koichi , Yano Seiji
Published: April 2023

Combination of alectinib and bortezomib induces apoptosis by upregulation of Noxa. A, Protein expression by western blotting in A925L cells treated with alectinib (3 Âµmol/L) and/or brotezomib (5 nmol/L) for 72 hours. B, the cells were treated with DMSO, alectinib (3 Âµmol/L), ixazomib (5 nmol/L), or a combination of alectinib (3 Âµmol/L) and ixazomib (5 nmol/L) for 9 d which were replenished every 72Â€‰h (right). The plates were stained with crystal violet and visually examined. A plate representative of three independent experiments is shown. C, Protein expression in A925L cells and H2228 cells transfected by siRNA control (scramble) or Noxa siRNA (si Noxa) which were treated with a combination of alectinib (3 Âµmol/L) and ixazomib (5 nmol/L) for 48 h. D, Western blotting of A925L cells overexpressing Noxa protein which were treated with alectinib (3Â€‰Âµmol/L) for 72 hours. E, Ubiquitinated Noxa protein in A925L cells which were treated with bortezomib (5Â€‰nmol/L) for 48 hours. N, C and B respectively correspond to non-specific, control and bortezomib. F, Protein expression in A925L cells detected by western blotting with immunoprecipitation of indicated proteins. Cell lines were treated with bortezomib (5Â€‰nmol/L) for 6 and 24 hours.
Figure S4 from Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
Authors: Spassova Ivelina , Ugurel Selma , Terheyden Patrick , Sucker Antje , Hassel Jessica C. , Ritter Cathrin , Kubat Linda , Habermann Daniel , Farahpour Farnoush , Saeedghalati Mohammadkarim , Peiffer Lukas , Kumar Rajiv , Schrama David , Hoffmann Daniel , Schadendorf Dirk , Becker Jürgen C.
Published: April 2023

Supplementary Figure F4. GLIPH analysis for TCRB of TIL clustering the CDR3 sequence into convergence groups assumed to react with the same peptide/MHC class I complex for 5 patients.
Figure S1 from Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Authors: Tannir Nizar M. , Signoretti Sabina , Choueiri Toni K. , McDermott David F. , Motzer Robert J. , Flaifel Abdallah , Pignon Jean-Christophe , Ficial Miriam , Frontera Osvaldo Arén , George Saby , Powles Thomas , Donskov Frede , Harrison Michael R. , Barthélémy Philippe , Tykodi Scott S. , Kocsis Judit , Ravaud Alain , Rodriguez-Cid Jeronimo R. , Pal Sumanta K. , Murad Andre M. , Ishii Yuko , Saggi Shruti Shally , McHenry M. Brent , Rini Brian I.
Published: April 2023

Post hoc identification of patients with sRCC in CheckMate214.
Supplementary Data from Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)
Authors: Innocenti Federico , Sibley Alexander B. , Patil Sushant A. , Etheridge Amy S. , Jiang Chen , Ou Fang-Shu , Howell Stefanie D. , Plummer Sarah J. , Casey Graham , Bertagnolli Monica M. , McLeod Howard L. , Auman James T. , Blanke Charles D. , Furukawa Yoichi , Venook Alan P. , Kubo Michiaki , Lenz Heinz-Josef , Parker Joel S. , Ratain Mark J. , Owzar Kouros
Published: April 2023

Supplementary Figures 1-5 and Supplementary Tables 1-5
Supplementary Data from Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells
Authors: Lemm Elizabeth A. , Valle-Argos Beatriz , Smith Lindsay D. , Richter Johanna , Gebreselassie Yohannes , Carter Matthew J. , Karolova Jana , Svaton Michael , Helman Karel , Weston-Bell Nicola J. , Karydis Laura , Williamson Chris T. , Lenz Georg , Pettigrew Jeremy , Harwig Curtis , Stevenson Freda K. , Cragg Mark , Forconi Francesco , Steele Andrew J. , Cross Jennifer , Mackenzie Lloyd , Klener Pavel , Packham Graham
Published: April 2023

Supplementary data
Supplementary Appendix from Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia
Authors: Zeidner Joshua F. , Lee Daniel J. , Frattini Mark , Fine Gil D. , Costas Judy , Kolibaba Kathryn , Anthony Stephen P. , Bearss David , Smith B. Douglas
Published: April 2023

Supplementary Appendix
Supplementary Table 1 from Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
Authors: Guo Jimmy A. , Hoffman Hannah I. , Shroff Stuti G. , Chen Peter , Hwang Peter G. , Kim Daniel Y. , Kim Daniel W. , Cheng Stephanie W. , Zhao Daniel , Mahal Brandon A. , Alshalalfa Mohammed , Niemierko Andrzej , Wo Jennifer Y. , Loeffler Jay S. , Fernandez-del Castillo Carlos , Jacks Tyler , Aguirre Andrew J. , Hong Theodore S. , Mino-Kenudson Mari , Hwang William L.
Published: April 2023

Supplementary Table 1
Table S4 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
Authors: Guerini-Rocco Elena , Gray Kathryn P. , Fumagalli Caterina , Reforgiato Marta Rita , Leone Isabella , Rafaniello Raviele Paola , Munzone Elisabetta , Kammler Roswitha , Neven Patrick , Hitre Erika , Jerusalem Guy , Simoncini Edda , Gombos Andrea , Deleu Ines , Karlsson Per , Aebi Stefan , Chirgwin Jacquie , Di Lauro Vincenzo , Thompson Alastair , Graas Marie-Pascale , Barber Matthew , Fontaine Christel , Loibl Sibylle , Gavilá Joaquín , Kuroi Katsumasa , Müller Bettina , O’Reilly Seamus , Di Leo Angelo , Goldhirsch Aron , Viale Giuseppe , Barberis Massimo , Regan Meredith M. , Colleoni Marco
Published: April 2023

Associations of recurrent gene single-nucleotide variant/copy number gain with clinic-pathological factors.
Figure S2 from Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
Authors: Guerini-Rocco Elena , Gray Kathryn P. , Fumagalli Caterina , Reforgiato Marta Rita , Leone Isabella , Rafaniello Raviele Paola , Munzone Elisabetta , Kammler Roswitha , Neven Patrick , Hitre Erika , Jerusalem Guy , Simoncini Edda , Gombos Andrea , Deleu Ines , Karlsson Per , Aebi Stefan , Chirgwin Jacquie , Di Lauro Vincenzo , Thompson Alastair , Graas Marie-Pascale , Barber Matthew , Fontaine Christel , Loibl Sibylle , Gavilá Joaquín , Kuroi Katsumasa , Müller Bettina , O’Reilly Seamus , Di Leo Angelo , Goldhirsch Aron , Viale Giuseppe , Barberis Massimo , Regan Meredith M. , Colleoni Marco
Published: April 2023

Weighted Kaplan-Meier (KM) estimates of breast cancer-free interval (BCFI) and distant recurrence-free interval (DRFI) according to tumor subtype, separately by PIK3CA mutational status (mutated, MUT vs wild-type, WT). The 5-year event-free estimates (95% CI) are provided. Hazard ratio (HR) estimates (95% CI) and log-rank tests from weighted univariate models.
Supplementary Data from Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment
Authors: Sathe Anuja , Grimes Susan M. , Lau Billy T. , Chen Jiamin , Suarez Carlos , Huang Robert J. , Poultsides George , Ji Hanlee P.
Published: April 2023

Supplementary methods, legends to supplementary figures and tables, supplementary figures and tables
Supplementary Table 1 from Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Authors: Zhang Ian Y. , Zhou Hui , Liu Huili , Zhang Leying , Gao Hang , Liu Shunan , Song Yanyan , Alizadeh Darya , Yin Hongwei Holly , Pillai Raju , Badie Behnam
Published: April 2023

Supplementary Table 1
Supplementary Figure 6 from Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Authors: Zhang Ian Y. , Zhou Hui , Liu Huili , Zhang Leying , Gao Hang , Liu Shunan , Song Yanyan , Alizadeh Darya , Yin Hongwei Holly , Pillai Raju , Badie Behnam
Published: April 2023

Supplementary Figure 6
Supplementary Figure 2 from Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Authors: Zhang Ian Y. , Zhou Hui , Liu Huili , Zhang Leying , Gao Hang , Liu Shunan , Song Yanyan , Alizadeh Darya , Yin Hongwei Holly , Pillai Raju , Badie Behnam
Published: April 2023

Supplementary Figure 2
Supplementary Figure 1 from Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Authors: Zhang Ian Y. , Zhou Hui , Liu Huili , Zhang Leying , Gao Hang , Liu Shunan , Song Yanyan , Alizadeh Darya , Yin Hongwei Holly , Pillai Raju , Badie Behnam
Published: April 2023

Supplementary Figure 1
Supplementary Data from The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models In Vivo Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ
Authors: Yang Yuan , Yang Howard H. , Tang Binwu , Wu Alex Man Lai , Flanders Kathleen C. , Moshkovich Nellie , Weinberg Douglas S. , Welsh Michael A. , Weng Jia , Ochoa Humberto J. , Hu Tiffany Y. , Herrmann Michelle A. , Chen Jinqiu , Edmondson Elijah F. , Simpson R. Mark , Liu Fang , Liu Huaitian , Lee Maxwell P. , Wakefield Lalage M.
Published: April 2023

Supplementary Materials and Methods and Supplementary Figures S1-S10
Supplementary Table 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
Authors: LeBlanc Amy K. , Mazcko Christina N. , Cherukuri Aswini , Berger Erika P. , Kisseberth William C. , Brown Megan E. , Lana Susan E. , Weishaar Kristen , Flesner Brian K. , Bryan Jeffrey N. , Vail David M. , Burton Jenna H. , Willcox Jennifer L. , Mutsaers Anthony J. , Woods J. Paul , Northrup Nicole C. , Saba Corey , Curran Kaitlin M. , Leeper Haley , Wilson-Robles Heather , Wustefeld-Janssens Brandan G. , Lindley Stephanie , Smith Annette N. , Dervisis Nikolaos , Klahn Shawna , Higginbotham Mary Lynn , Wouda Raelene M. , Krick Erika , Mahoney Jennifer A. , London Cheryl A. , Barber Lisa G. , Balkman Cheryl E. , McCleary-Wheeler Angela L. , Suter Steven E. , Martin Olya , Borgatti Antonella , Burgess Kristine , Childress Michael O. , Fidel Janean L. , Allstadt Sara D. , Gustafson Daniel L. , Selmic Laura E. , Khanna Chand , Fan Timothy M.
Published: April 2023

Supplementary Table 2 contains the summary comparison of both the Intent-to-treat and Per-protocol analyses of clinical outcomes for dogs enrolled in Standard of Care (SOC) and Standard of Care + sirolimus
Supplementary Legend from Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
Authors: Ogura Koichi , Somwar Romel , Hmeljak Julija , Magnan Heather , Benayed Ryma , Momeni Boroujeni Amir , Bowman Anita S. , Mattar Marissa S. , Khodos Inna , de Stanchina Elisa , Jungbluth Achim , Asher Marina , Odintsov Igor , Hartono Alifiani B. , LaQuaglia Michael P. , Slotkin Emily , Pratilas Christine A. , Lee Sean Bong , Spraggon Lee , Ladanyi Marc
Published: April 2023

Supplementary Legend
Supplementary Data from Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
Authors: Ogura Koichi , Somwar Romel , Hmeljak Julija , Magnan Heather , Benayed Ryma , Momeni Boroujeni Amir , Bowman Anita S. , Mattar Marissa S. , Khodos Inna , de Stanchina Elisa , Jungbluth Achim , Asher Marina , Odintsov Igor , Hartono Alifiani B. , LaQuaglia Michael P. , Slotkin Emily , Pratilas Christine A. , Lee Sean Bong , Spraggon Lee , Ladanyi Marc
Published: April 2023

Supplementary Table 3
Figure S3 from Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
Authors: Ogura Koichi , Somwar Romel , Hmeljak Julija , Magnan Heather , Benayed Ryma , Momeni Boroujeni Amir , Bowman Anita S. , Mattar Marissa S. , Khodos Inna , de Stanchina Elisa , Jungbluth Achim , Asher Marina , Odintsov Igor , Hartono Alifiani B. , LaQuaglia Michael P. , Slotkin Emily , Pratilas Christine A. , Lee Sean Bong , Spraggon Lee , Ladanyi Marc
Published: April 2023

Supplementary Figure 3. Ectopic overexpression of EWSR1-WT1 +KTS and -KTS in UF5 cells.
Supplementary Files from A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer
Authors: Kazmi Farasat , Nicum Shibani , Roux Rene L. , Spiers Laura , Gnanaranjan Chat , Sukumaran Ajithkumar , Gabra Hani , Ghazaly Essam , McCracken Nigel W. , Harrison David J. , Blagden Sarah P.
Published: April 2023

Supplementary Methods and Tables
Supplementary Tables from Female Immunity Protects from Cutaneous Squamous Cell Carcinoma
Authors: Budden Timothy , Gaudy-Marqueste Caroline , Craig Sarah , Hu Yuan , Earnshaw Charles H. , Gurung Shilpa , Ra Amelle , Akhras Victoria , Shenjere Patrick , Green Ruth , Jamieson Lynne , Lear John , Motta Luisa , Caulín Carlos , Oudit Deemesh , Furney Simon J. , Virós Amaya
Published: April 2023

Supplementary Tables 1-6
Table S5 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
Authors: Yu Helena A. , Paz-Ares Luis G. , Yang James Chih-Hsin , Lee Ki Hyeong , Garrido Pilar , Park Keunchil , Kim Joo-Hang , Lee Dae Ho , Mao Huzhang , Wijayawardana Sameera R. , Gao Ling , Hozak Rebecca R. , Chao Bo H. , Planchard David
Published: April 2023

Confirmed Best Overall Central Nervous System Response
Table S2 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
Authors: Yu Helena A. , Paz-Ares Luis G. , Yang James Chih-Hsin , Lee Ki Hyeong , Garrido Pilar , Park Keunchil , Kim Joo-Hang , Lee Dae Ho , Mao Huzhang , Wijayawardana Sameera R. , Gao Ling , Hozak Rebecca R. , Chao Bo H. , Planchard David
Published: April 2023

Treatment-related Adverse Events by CTCAE Grade and MedDRA System Organ Class and Preferred Term
Figure S2 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
Authors: Yu Helena A. , Paz-Ares Luis G. , Yang James Chih-Hsin , Lee Ki Hyeong , Garrido Pilar , Park Keunchil , Kim Joo-Hang , Lee Dae Ho , Mao Huzhang , Wijayawardana Sameera R. , Gao Ling , Hozak Rebecca R. , Chao Bo H. , Planchard David
Published: April 2023

Overall survival
Figure S1 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
Authors: Yu Helena A. , Paz-Ares Luis G. , Yang James Chih-Hsin , Lee Ki Hyeong , Garrido Pilar , Park Keunchil , Kim Joo-Hang , Lee Dae Ho , Mao Huzhang , Wijayawardana Sameera R. , Gao Ling , Hozak Rebecca R. , Chao Bo H. , Planchard David
Published: April 2023

Patient disposition
Supplementary figures 1a-1c from Circulating Tumor Cells and Early Relapse in Node-positive Melanoma
Authors: Lucci Anthony , Hall Carolyn S. , Patel Sapna P. , Narendran Boomadevi , Bauldry Jessica B. , Royal Richard E. , Karhade Mandar , Upshaw Joshua R. , Wargo Jennifer A. , Glitza Isabella C. , Wong Michael K.K. , Amaria Rodabe N. , Tawbi Hussein A. , Diab Adi , Davies Michael A. , Gershenwald Jeffrey E. , Lee Jeffrey E. , Hwu Patrick , Ross Merrick I.
Published: April 2023

Box and Whisker Plots
Supplementary Data from Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma
Authors: Alewine Christine , Ahmad Mehwish , Peer Cody J. , Hu Zishuo I. , Lee Min-Jung , Yuno Akira , Kindrick Jessica D. , Thomas Anish , Steinberg Seth M. , Trepel Jane B. , Figg William D. , Hassan Raffit , Pastan Ira
Published: April 2023

Supplemental Figure 4
Supplemental Table 3 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence
Authors: Xie Hao , Mahoney Douglas W. , Foote Patrick H. , Burger Kelli N. , Doering Karen A. , Taylor William R. , Then Sara S. , Cao Xiaoming , McGlinch Maria , Berger Calise K. , Wu Tsung-Teh , Hubbard Joleen M. , Allawi Hatim T. , Kaiser Michael W. , Lidgard Graham P. , Ahlquist David A. , Kisiel John B.
Published: April 2023

Supplemental Table 3 Performance of MDMs in differentiating recurrent CRC from healthy controls in MDM Plasma CRC Surveillance Study. MDM: methylated DNA marker; CRC: colorectal cancer; AUC: area under the receiver operating characteristic curve; CI: confidence interval; NED: no radiographic evidence of disease.
Figure S4 from Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)
Authors: Sharma Priyanka , Kimler Bruce F. , O'Dea Anne , Nye Lauren , Wang Yen Y. , Yoder Rachel , Staley Joshua M. , Prochaska Lindsey , Wagner Jamie , Amin Amanda L. , Larson Kelsey , Balanoff Christa , Elia Manana , Crane Gregory , Madhusudhana Sheshadri , Hoffmann Marc , Sheehan Maureen , Rodriguez Roberto , Finke Karissa , Shah Rajvi , Satelli Deepti , Shrestha Anuj , Beck Larry , McKittrick Richard , Pluenneke Robert , Raja Vinay , Beeki Venkatadri , Corum Larry , Heldstab Jaimie , LaFaver Stephanie , Prager Micki , Phadnis Milind , Mudaranthakam Dinesh Pal , Jensen Roy A. , Godwin Andrew K. , Salgado Roberto , Mehta Kathan , Khan Qamar
Published: April 2023

Treatment completion by study arm
Figure S2 from Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)
Authors: Sharma Priyanka , Kimler Bruce F. , O'Dea Anne , Nye Lauren , Wang Yen Y. , Yoder Rachel , Staley Joshua M. , Prochaska Lindsey , Wagner Jamie , Amin Amanda L. , Larson Kelsey , Balanoff Christa , Elia Manana , Crane Gregory , Madhusudhana Sheshadri , Hoffmann Marc , Sheehan Maureen , Rodriguez Roberto , Finke Karissa , Shah Rajvi , Satelli Deepti , Shrestha Anuj , Beck Larry , McKittrick Richard , Pluenneke Robert , Raja Vinay , Beeki Venkatadri , Corum Larry , Heldstab Jaimie , LaFaver Stephanie , Prager Micki , Phadnis Milind , Mudaranthakam Dinesh Pal , Jensen Roy A. , Godwin Andrew K. , Salgado Roberto , Mehta Kathan , Khan Qamar
Published: April 2023

CONSORT diagram
Figure S1 from Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)
Authors: Sharma Priyanka , Kimler Bruce F. , O'Dea Anne , Nye Lauren , Wang Yen Y. , Yoder Rachel , Staley Joshua M. , Prochaska Lindsey , Wagner Jamie , Amin Amanda L. , Larson Kelsey , Balanoff Christa , Elia Manana , Crane Gregory , Madhusudhana Sheshadri , Hoffmann Marc , Sheehan Maureen , Rodriguez Roberto , Finke Karissa , Shah Rajvi , Satelli Deepti , Shrestha Anuj , Beck Larry , McKittrick Richard , Pluenneke Robert , Raja Vinay , Beeki Venkatadri , Corum Larry , Heldstab Jaimie , LaFaver Stephanie , Prager Micki , Phadnis Milind , Mudaranthakam Dinesh Pal , Jensen Roy A. , Godwin Andrew K. , Salgado Roberto , Mehta Kathan , Khan Qamar
Published: April 2023

NeoSTOP study schema
Supplemental Figure 3 from Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence
Authors: Xie Hao , Mahoney Douglas W. , Foote Patrick H. , Burger Kelli N. , Doering Karen A. , Taylor William R. , Then Sara S. , Cao Xiaoming , McGlinch Maria , Berger Calise K. , Wu Tsung-Teh , Hubbard Joleen M. , Allawi Hatim T. , Kaiser Michael W. , Lidgard Graham P. , Ahlquist David A. , Kisiel John B.
Published: April 2023

Supplemental Figure 3: The distribution of MDMs in MDM Plasma CRC Early Primary Detection Study (i.e., training data) and in MDM Plasma CRC Surveillance Study (i.e., Recurrence data). There are reference lines relative to the healthy controls (blue line) and stage IV cancers (orange line). These reference lines are helpful in assessing drifts between patient populations.
Supplementary Data from Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: Hollebecque Antoine , Salvagni Stefania , Plummer Ruth , Isambert Nicolas , Niccoli Patricia , Capdevila Jaume , Curigliano Giuseppe , Moreno Victor , Martin-Romano Patricia , Baudin Eric , Arias Marina , Mora Sheila , de Alvaro Juan , Di Martino Jorge , Parra-Palau Josep L. , Sánchez-Pérez Tania , Aronchik Ida , Filvaroff Ellen H. , Lamba Manisha , Nikolova Zariana , de Bono Johann S.
Published: April 2023

SUPPLEMENTARY TABLES AND FIGURES
Supplementary Tables from Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma
Authors: Daemen Anneleen , Cooper Jonathan E. , Myrta Szymon , Wongchenko Matthew J. , Lin Eva , Long Jason E. , Foreman Oded , Modrusan Zora , Tremayne Jarrod R. , de la Cruz Cecile C. , Merchant Mark , Martin Scott E. , Yan Yibing , Junttila Melissa R.
Published: April 2023

Tables S1-S9
Supplementary Material from Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial
Authors: Hiller Jonathan G. , Cole Steven W. , Crone Elizabeth M. , Byrne David J. , Shackleford David M. , Pang Jia-Min B. , Henderson Michael A. , Nightingale Sophie S. , Ho Kwok M. , Myles Paul S. , Fox Stephen , Riedel Bernhard , Sloan Erica K.
Published: April 2023

Supplementary Material
Supplemental FigureS1 from Molecular Biomarkers of Response to Eribulin in Patients with Leiomyosarcoma
Authors: Wozniak Agnieszka , Boeckx Bram , Modave Elodie , Weaver Amy , Lambrechts Diether , Littlefield Bruce A. , Schöffski Patrick
Published: April 2023

Example of CNA profiles obtained in LMS. Copy-number plots: x-axis represents the position on the full genome (chromosome numbers are indicated). Red dots represent normalized read count for bins of 50Kb (log R value). Y-values around 0 represent copy-number (CN) of 2 (grey line). Lower values indicate a deletion and higher values indicate a gain. The horizontal green line represents the segmented CN profiles
Figure S1 from Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma
Authors: Daemen Anneleen , Cooper Jonathan E. , Myrta Szymon , Wongchenko Matthew J. , Lin Eva , Long Jason E. , Foreman Oded , Modrusan Zora , Tremayne Jarrod R. , de la Cruz Cecile C. , Merchant Mark , Martin Scott E. , Yan Yibing , Junttila Melissa R.
Published: April 2023

Supplemental Figure 1. Subtype identification in early/advanced LUAD.
Figure S2 from Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
Authors: Anastasiadou Eleni , Seto Anita G. , Beatty Xuan , Hermreck Melanie , Gilles Maud-Emmanuelle , Stroopinsky Dina , Pinter-Brown Lauren C. , Pestano Linda , Marchese Cinzia , Avigan David , Trivedi Pankaj , Escolar Diana M. , Jackson Aimee L. , Slack Frank J.
Published: April 2023

Supplementary figure S2
Figure S5 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Authors: Yi Yuxi , Shen Lijun , Shi Wei , Xia Fan , Zhang Hui , Wang Yan , Zhang Jing , Wang Yaqi , Sun Xiaoyang , Zhang Zhiyuan , Zou Wei , Yang Wang , Zhang Lingyi , Zhu Ji , Goel Ajay , Ma Yanlei , Zhang Zhen
Published: April 2023

Supplementary figures showing the performance of the response-prediction classifier based on microbial and clinical variables.
Figure S1 from Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
Authors: Anastasiadou Eleni , Seto Anita G. , Beatty Xuan , Hermreck Melanie , Gilles Maud-Emmanuelle , Stroopinsky Dina , Pinter-Brown Lauren C. , Pestano Linda , Marchese Cinzia , Avigan David , Trivedi Pankaj , Escolar Diana M. , Jackson Aimee L. , Slack Frank J.
Published: April 2023

Supplementary figure S1
Figure S3 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Authors: Yi Yuxi , Shen Lijun , Shi Wei , Xia Fan , Zhang Hui , Wang Yan , Zhang Jing , Wang Yaqi , Sun Xiaoyang , Zhang Zhiyuan , Zou Wei , Yang Wang , Zhang Lingyi , Zhu Ji , Goel Ajay , Ma Yanlei , Zhang Zhen
Published: April 2023

Supplementary figures showing that the gut microbiome variations over the course of nCRT associated with therapeutic response.
Figure S2 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Authors: Yi Yuxi , Shen Lijun , Shi Wei , Xia Fan , Zhang Hui , Wang Yan , Zhang Jing , Wang Yaqi , Sun Xiaoyang , Zhang Zhiyuan , Zou Wei , Yang Wang , Zhang Lingyi , Zhu Ji , Goel Ajay , Ma Yanlei , Zhang Zhen
Published: April 2023

Supplementary figures showing that the gut microbiome in LARC patients differed significantly from that in healthy individuals.
Supplemental Figure 5 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial
Authors: Patnaik Amita , Yap Timothy A. , Chung Hyun Cheol , de Miguel Maria J. , Bang Yung-Jue , Lin Chia-Chi , Su Wu-Chou , Italiano Antoine , Chow Kay Hoong , Szpurka Anna M. , Yu Danni , Zhao Yumin , Carlsen Michelle , Schmidt Shelly , Vangerow Burkhard , Gandhi Leena , Xu Xiaojian , Bendell Johanna
Published: April 2023

T-cell proliferation and activation marker changes
Supplemental Figure 2 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial
Authors: Patnaik Amita , Yap Timothy A. , Chung Hyun Cheol , de Miguel Maria J. , Bang Yung-Jue , Lin Chia-Chi , Su Wu-Chou , Italiano Antoine , Chow Kay Hoong , Szpurka Anna M. , Yu Danni , Zhao Yumin , Carlsen Michelle , Schmidt Shelly , Vangerow Burkhard , Gandhi Leena , Xu Xiaojian , Bendell Johanna
Published: April 2023

Swimmer plots of PD-L1 inhibitor monotherapy and ramucirumab + PD-L1 inhibitor combination cohorts
Figure S7 from A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Authors: Mathur Divya , Root Adam R. , Bugaj-Gaweda Bozena , Bisulco Stephanie , Tan Xingzhi , Fang Wei , Kearney Jessica C. , Lucas Justin , Guffroy Magali , Golas Jonathan , Rohde Cynthia M. , Stevens Chad , Kamperschroer Cris , Kelleher Kerry , Lawrence-Henderson Rosemary F. , Upeslacis Erik , Yao Johnny , Narula Jatin , LaVallie Edward R. , Fernandez Diane R. , Buetow Bernard S. , Rosfjord Edward , Bloom Laird , King Lindsay E. , Tchistiakova Lioudmila , Nguyen Anhco , Sapra Puja
Published: April 2023

PF-07062119 binds to Cynomolgus Monkey T cells
Figure S6 from A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Authors: Mathur Divya , Root Adam R. , Bugaj-Gaweda Bozena , Bisulco Stephanie , Tan Xingzhi , Fang Wei , Kearney Jessica C. , Lucas Justin , Guffroy Magali , Golas Jonathan , Rohde Cynthia M. , Stevens Chad , Kamperschroer Cris , Kelleher Kerry , Lawrence-Henderson Rosemary F. , Upeslacis Erik , Yao Johnny , Narula Jatin , LaVallie Edward R. , Fernandez Diane R. , Buetow Bernard S. , Rosfjord Edward , Bloom Laird , King Lindsay E. , Tchistiakova Lioudmila , Nguyen Anhco , Sapra Puja
Published: April 2023

Mouse body weights of CT26-mGUCY2C tumor bearing hCD3ε transgenic mice treated with PF-07062119
Figure S5 from A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Authors: Mathur Divya , Root Adam R. , Bugaj-Gaweda Bozena , Bisulco Stephanie , Tan Xingzhi , Fang Wei , Kearney Jessica C. , Lucas Justin , Guffroy Magali , Golas Jonathan , Rohde Cynthia M. , Stevens Chad , Kamperschroer Cris , Kelleher Kerry , Lawrence-Henderson Rosemary F. , Upeslacis Erik , Yao Johnny , Narula Jatin , LaVallie Edward R. , Fernandez Diane R. , Buetow Bernard S. , Rosfjord Edward , Bloom Laird , King Lindsay E. , Tchistiakova Lioudmila , Nguyen Anhco , Sapra Puja
Published: April 2023

Mouse body weights of LS1034 colon orthotopic tumor bearing mice treated with PF-07062119 using adoptive T cell transfer
Table S2 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
Authors: Foltz Jennifer A. , Hess Brian T. , Bachanova Veronika , Bartlett Nancy L. , Berrien-Elliott Melissa M. , McClain Ethan , Becker-Hapak Michelle , Foster Mark , Schappe Timothy , Kahl Brad , Mehta-Shah Neha , Cashen Amanda F. , Marin Nancy D. , McDaniels Kristen , Moreno Chaz , Mosior Matthew , Gao Feng , Griffith Obi L. , Griffith Malachi , Wagner Julia A. , Epperla Narendranath , Rock Amy D. , Lee John , Petti Allegra A. , Soon-Shiong Patrick , Fehniger Todd A.
Published: April 2023

CITE-seq Antibody Panel
Figure S2 from A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Authors: Mathur Divya , Root Adam R. , Bugaj-Gaweda Bozena , Bisulco Stephanie , Tan Xingzhi , Fang Wei , Kearney Jessica C. , Lucas Justin , Guffroy Magali , Golas Jonathan , Rohde Cynthia M. , Stevens Chad , Kamperschroer Cris , Kelleher Kerry , Lawrence-Henderson Rosemary F. , Upeslacis Erik , Yao Johnny , Narula Jatin , LaVallie Edward R. , Fernandez Diane R. , Buetow Bernard S. , Rosfjord Edward , Bloom Laird , King Lindsay E. , Tchistiakova Lioudmila , Nguyen Anhco , Sapra Puja
Published: April 2023

Mouse body weights of LS1034 tumor bearing mice treated with GUCY2C(M)-CD3 using adoptive T cell transfer
Supplementary Data from Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer
Authors: Williams Christopher J.M. , Seligmann Jenny F. , Elliott Faye , Shires Michael , Richman Susan D. , Brown Sarah , Zhang Liping , Singh Shalini , Pugh Judith , Xu Xiao-Meng , Muranyi Andrea , Guetter Christoph , Lorsakul Auranuch , Kurkure Uday , Zhao Zuo , Martin Jim , Wang Xingwei , Nguyen Kien , Liu Wen-Wei , Yan Dongyao , West Nicholas P. , Barrett Jennifer H. , Barnes Michael , Bai Isaac , Seymour Matthew T. , Quirke Philip , Shanmugam Kandavel
Published: April 2023

Table S1: Baseline patient demographics and disease characteristics. Table S2: mRNA/IHC AREG/EREG concordance table. Figure S1: AREG/EREG IHC scatterplot. Table S3: Prognostic effect of dichotomous AREG/EREG. Table S4: AREG/EREG and RECIST response rate. Table S5: AREG and EREG as individual continuous variables. Table S6: AREG/EREG predictive analyses adjusted for BRAF mutation, PTL and peritoneal metastases. Table S7: Exploratory analyses of different AREG/EREG cut points. Table S8: AREG/EREG IHC in biopsy and resection specimens.
Figure S3 from Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
Authors: Foltz Jennifer A. , Hess Brian T. , Bachanova Veronika , Bartlett Nancy L. , Berrien-Elliott Melissa M. , McClain Ethan , Becker-Hapak Michelle , Foster Mark , Schappe Timothy , Kahl Brad , Mehta-Shah Neha , Cashen Amanda F. , Marin Nancy D. , McDaniels Kristen , Moreno Chaz , Mosior Matthew , Gao Feng , Griffith Obi L. , Griffith Malachi , Wagner Julia A. , Epperla Narendranath , Rock Amy D. , Lee John , Petti Allegra A. , Soon-Shiong Patrick , Fehniger Todd A.
Published: April 2023

CITE-seq reveals N-803 and rituximab mediated activation of PB NK cells
Supplementary File 8: Olaparib Pharmacokinetics. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Authors: de Haan Rosemarie , van den Heuvel Michel M. , van Diessen Judi , Peulen Heike M.U. , van Werkhoven Erik , de Langen Adrianus J. , Lalezari Ferry , Pluim Dick , Verwijs-Janssen Manon , Vens Conchita , Schellens Jan H.M. , Steeghs Neeltje , Verheij Marcel , van Triest Baukelien
Published: April 2023

This file contains details on the pharmacokinetic profile (I) and parameters (II) of olaparib.
Supplementary File 6: Pulmonary Function Tests and Pulmonary Adverse Events by Treatment Arm. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Authors: de Haan Rosemarie , van den Heuvel Michel M. , van Diessen Judi , Peulen Heike M.U. , van Werkhoven Erik , de Langen Adrianus J. , Lalezari Ferry , Pluim Dick , Verwijs-Janssen Manon , Vens Conchita , Schellens Jan H.M. , Steeghs Neeltje , Verheij Marcel , van Triest Baukelien
Published: April 2023

This file contains details on pulmonary function changes in diffusion tests (I) and spirometry tests (II), and the incidence of severe pulmonary adverse events by treatment arm (III).
Supplementary File 4: Adverse Events. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Authors: de Haan Rosemarie , van den Heuvel Michel M. , van Diessen Judi , Peulen Heike M.U. , van Werkhoven Erik , de Langen Adrianus J. , Lalezari Ferry , Pluim Dick , Verwijs-Janssen Manon , Vens Conchita , Schellens Jan H.M. , Steeghs Neeltje , Verheij Marcel , van Triest Baukelien
Published: April 2023

This file contains details on adverse events in the CCRT arm at all olaparib doses (I) and in the (SC)RT arm at olaparib 25mg BID (II) and 25mg QD (III) separately.
Supplementary File 2: Treatment details. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Authors: de Haan Rosemarie , van den Heuvel Michel M. , van Diessen Judi , Peulen Heike M.U. , van Werkhoven Erik , de Langen Adrianus J. , Lalezari Ferry , Pluim Dick , Verwijs-Janssen Manon , Vens Conchita , Schellens Jan H.M. , Steeghs Neeltje , Verheij Marcel , van Triest Baukelien
Published: April 2023

This file contains the radiation doses to organs at risk (I) and details on systemic treatment (II).
Supplementary File 1: Supplementary Methods. from Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
Authors: de Haan Rosemarie , van den Heuvel Michel M. , van Diessen Judi , Peulen Heike M.U. , van Werkhoven Erik , de Langen Adrianus J. , Lalezari Ferry , Pluim Dick , Verwijs-Janssen Manon , Vens Conchita , Schellens Jan H.M. , Steeghs Neeltje , Verheij Marcel , van Triest Baukelien
Published: April 2023

This file contains Supplementary Methods: radiotherapy details (I), treatment schedules (II), definition of Dose Limiting Toxicity (III) and a schedule of assessments (IV).
Supplementary Figures from MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Authors: Dagogo-Jack Ibiayi , Yoda Satoshi , Lennerz Jochen K. , Langenbucher Adam , Lin Jessica J. , Rooney Marguerite M. , Prutisto-Chang Kylie , Oh Audris , Adams Nathaniel A. , Yeap Beow Y. , Chin Emily , Do Andrew , Marble Hetal D. , Stevens Sara E. , Digumarthy Subba R. , Saxena Ashish , Nagy Rebecca J. , Benes Cyril H. , Azzoli Christopher G. , Lawrence Michael S. , Gainor Justin F. , Shaw Alice T. , Hata Aaron N.
Published: April 2023

Supplementary Figure 1-5
Supplementary Data from MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
Authors: Dagogo-Jack Ibiayi , Yoda Satoshi , Lennerz Jochen K. , Langenbucher Adam , Lin Jessica J. , Rooney Marguerite M. , Prutisto-Chang Kylie , Oh Audris , Adams Nathaniel A. , Yeap Beow Y. , Chin Emily , Do Andrew , Marble Hetal D. , Stevens Sara E. , Digumarthy Subba R. , Saxena Ashish , Nagy Rebecca J. , Benes Cyril H. , Azzoli Christopher G. , Lawrence Michael S. , Gainor Justin F. , Shaw Alice T. , Hata Aaron N.
Published: April 2023

supplementary tables, figure legends, methods
Supplementary Data from Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics
Authors: Kato Shumei , Adashek Jacob J. , Shaya Justin , Okamura Ryosuke , Jimenez Rebecca E. , Lee Suzanna , Sicklick Jason K. , Kurzrock Razelle
Published: April 2023

Supplemental Table 1 and Supplemental Figure 1
Supplementary Figure S2 from Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases
Authors: Angus Lindsay , Deger Teoman , Jager Agnes , Martens John W.M. , de Weerd Vanja , van Heuvel Irene , van den Bent Martin J. , Sillevis Smitt Peter A.E. , Kros Johan M. , Bindels Eric M.J. , Heitzer Ellen , Sleijfer Stefan , Jongen Joost L.M. , Wilting Saskia M.
Published: April 2023

Correlation between input ng cfDNA in the Oncomine Breast V2 breast panel and the median molecular coverage (i.e., the median number of uniquely
Supplementary Data from Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases
Authors: Angus Lindsay , Deger Teoman , Jager Agnes , Martens John W.M. , de Weerd Vanja , van Heuvel Irene , van den Bent Martin J. , Sillevis Smitt Peter A.E. , Kros Johan M. , Bindels Eric M.J. , Heitzer Ellen , Sleijfer Stefan , Jongen Joost L.M. , Wilting Saskia M.
Published: April 2023

Supplementary Tables
Supplementary File 1 from Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
Authors: Janku Filip , Zhang Halle Huihong , Pezeshki Abdulmohammad , Goel Sanjay , Murthy Ravi , Wang-Gillam Andrea , Shepard Dale R. , Helgason Thorunn , Masters Tyler , Hong David S. , Piha-Paul Sarina A. , Karp Daniel D. , Klang Mark , Huang Steven Y. , Sakamuri Divya , Raina Anjali , Torrisi Jean , Solomon Stephen B. , Weissfeld Alice , Trevino Ernest , DeCrescenzo Gary , Collins Amanda , Miller Maria , Salstrom Jennifer L. , Korn Ronald L. , Zhang Linping , Saha Saurabh , Leontovich Alexey A. , Tung David , Kreider Brent , Varterasian Mary , Khazaie Khashayarsha , Gounder Mrinal M.
Published: April 2023

Study Protocol
Supplementary Figure S8 from Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Authors: Estrada-Bernal Adriana , Le Anh T. , Doak Andrea E. , Tirunagaru Vijaya G. , Silva Shevan , Bull Matthew R. , Smaill Jeff B. , Patterson Adam V. , Kim Chul , Liu Stephen V. , Doebele Robert C.
Published: April 2023

Body weight changes in tumor xenograft and PDX-bearing nude mice.
Table S2 from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers
Authors: Hu Zhiyuan , Cunnea Paula , Zhong Zhe , Lu Haonan , Osagie Oloruntoba I. , Campo Leticia , Artibani Mara , Nixon Katherine , Ploski Jennifer , Santana Gonzalez Laura , Alsaadi Abdulkhaliq , Wietek Nina , Damato Stephen , Dhar Sunanda , Blagden Sarah P. , Yau Christopher , Hester Joanna , Albukhari Ashwag , Aboagye Eric O. , Fotopoulou Christina , Ahmed Ahmed
Published: April 2023

Table S2. The QuPath classification results for the immunohistochemistry of CAPS in SOC tissue microarrays.
Supplementary Information from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers
Authors: Hu Zhiyuan , Cunnea Paula , Zhong Zhe , Lu Haonan , Osagie Oloruntoba I. , Campo Leticia , Artibani Mara , Nixon Katherine , Ploski Jennifer , Santana Gonzalez Laura , Alsaadi Abdulkhaliq , Wietek Nina , Damato Stephen , Dhar Sunanda , Blagden Sarah P. , Yau Christopher , Hester Joanna , Albukhari Ashwag , Aboagye Eric O. , Fotopoulou Christina , Ahmed Ahmed
Published: April 2023

Supplementary Figures and Tables
Table S2 from Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Authors: Zhang Jiajia , Ji Zhicheng , Caushi Justina X. , El Asmar Margueritta , Anagnostou Valsamo , Cottrell Tricia R. , Chan Hok Yee , Suri Prerna , Guo Haidan , Merghoub Taha , Chaft Jamie E. , Reuss Joshua E. , Tam Ada J. , Blosser Richard L. , Abu-Akeel Mohsen , Sidhom John-William , Zhao Ni , Ha Jinny S. , Jones David R. , Marrone Kristen A. , Naidoo Jarushka , Gabrielson Edward , Taube Janis M. , Velculescu Victor E. , Brahmer Julie R. , Housseau Franck , Hellmann Matthew D. , Forde Patrick M. , Pardoll Drew M. , Ji Hongkai , Smith Kellie N.
Published: April 2023

Correlative assays performed on each sample
Supplementary Figures from Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer
Authors: Zhang Jiajia , Ji Zhicheng , Caushi Justina X. , El Asmar Margueritta , Anagnostou Valsamo , Cottrell Tricia R. , Chan Hok Yee , Suri Prerna , Guo Haidan , Merghoub Taha , Chaft Jamie E. , Reuss Joshua E. , Tam Ada J. , Blosser Richard L. , Abu-Akeel Mohsen , Sidhom John-William , Zhao Ni , Ha Jinny S. , Jones David R. , Marrone Kristen A. , Naidoo Jarushka , Gabrielson Edward , Taube Janis M. , Velculescu Victor E. , Brahmer Julie R. , Housseau Franck , Hellmann Matthew D. , Forde Patrick M. , Pardoll Drew M. , Ji Hongkai , Smith Kellie N.
Published: April 2023

Figures S1-S8
Supplementary Table S1a from Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer
Authors: Vidula Neelima , Niemierko Andrzej , Malvarosa Giuliana , Yuen Megan , Lennerz Jochen , Iafrate A. John , Wander Seth A. , Spring Laura , Juric Dejan , Isakoff Steven , Younger Jerry , Moy Beverly , Ellisen Leif W. , Bardia Aditya
Published: April 2023

Supplemental Table S1a. Genes included in Guardant360® panel and related genotypedirected therapy.